Sirona Biochem names Sean Cunliffe CEO and director
This article was originally published in Scrip
Sirona Biochem, a biotech developing diabetes therapeutics and cancer vaccine antigens, has named Sean Cunliffe chief business officer and appointed him to the board of directors. Mr Cunliffe has over 25 year's pharmaceutical sales and marketing experience. Most recently he was senior vice-president of sales and marketing at Angiotech Pharmaceuticals, now Zalicus.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.